Allen Christopher, Poyorena Christopher, Querin Lauren B
Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.
Mayo Clinic Hospital Phoenix, Department of Emergency Medicine, Phoenix, Arizona.
Clin Pract Cases Emerg Med. 2024 Aug;8(3):250-253. doi: 10.5811/cpcem.19412.
ST-elevation myocardial infarction (STEMI) can be caused by underlying coronary artery vasospasm (CAV) with or without associated atherosclerotic disease. Coronary artery vasospasm is a rare but potentially devastating manifestation of eosinophilic granulomatosis with polyangiitis (EGPA).
We describe a 54-year-old male with a known history of EGPA and coronary artery disease presenting to the emergency department with chest pain and an inferior STEMI on electrocardiogram. He was ultimately taken for coronary angiography and found to have a discrete vasospastic lesion in the right coronary artery that was treated with intra-coronary nitroglycerin and calcium channel blockers. He was continued on immunosuppressant agents (prednisone and mepolizumab) for management of EGPA and followed up with outpatient cardiology and rheumatology for vasospastic angina.
This case highlights a rare cause of STEMI, discusses the nuances in treatment of STEMI due to CAV, and provides background on pathophysiology and treatment of EGPA.
ST段抬高型心肌梗死(STEMI)可由潜在的冠状动脉痉挛(CAV)引起,伴或不伴有相关的动脉粥样硬化疾病。冠状动脉痉挛是嗜酸性肉芽肿性多血管炎(EGPA)的一种罕见但可能具有毁灭性的表现。
我们描述了一名54岁男性,有EGPA和冠状动脉疾病史,因胸痛就诊于急诊科,心电图显示下壁STEMI。他最终接受了冠状动脉造影,发现右冠状动脉有一个离散的血管痉挛性病变,采用冠状动脉内硝酸甘油和钙通道阻滞剂进行了治疗。他继续使用免疫抑制剂(泼尼松和美泊利珠单抗)治疗EGPA,并由门诊心脏病学和风湿病学专家对血管痉挛性心绞痛进行随访。
本病例突出了STEMI的一种罕见病因,讨论了CAV所致STEMI治疗中的细微差别,并提供了EGPA病理生理学和治疗的背景知识。